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Purpose: Demonstrate unequivocally the generation of nitric oxide in experimental autoimmune uveoretinitis 
by electron spin resonance spectroscopy (ESR) using ferrous iron complex of N-methyl-D-glucamine 
dithiocarbamate, (MGD)2-Fe
2+, as a spin trap. 
Methods: Experimental autoimmune uveitis was induced in Lewis rats, and at the peak of the intraocular 
inflammation, the animals received intravitreous injections of the spin trap. The retina and choroid dissected 
from the enucleated globes were subjected to ESR. Similarly, the retina and choroid obtained at the peak 
of experimental autoimmune uveo-retinitis (EAU) were placed in a vial containing luminal, and 
chemiluminescence was counted on a Packard liquid scintillation analyzer. 
Results: The ESR three-line spectrum (g=2.04; aN=12.5 G) obtained was characteristic of the adduct 
[(MGD)2-Fe
2+-NO]. The majority of this signal was eliminated by the inducible nitric oxide synthase (iNOS) 
specific inhibitor aminoguanidine injected inflamed retina was detected when compared with that of the non 
inflamed controls. The chemiluminescent activity was further increased two-fold by the addition of 
bicarbonate to the inflamed retina; the phenomenon is attributable only to the presence of a high 
steady-state concentration of peroxynitrite.
Conclusions: The study shows an unequivocal presence of nitric oxide in EAU retina and choroid and the 
generation of peroxynitrite. High levels of these reactive nitrogen species generated in the inflamed retina 
and choroids are certain to cause irreversible tissue damage, especially at the susceptible sites such as 
photoreceptors. 
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Uveitis is a complex intraocular inflammatory process 
primarily involving the uvea, retina, and other intraocular 
structures. This intraocular inflammation can be either acute 
or chronic and is readily induced in laboratory animals by 
sensitization with the retinal soluble protein S-antigen. The 
resultant inflammation is known as experimental autoimmune 
uveo-retinitis (EAU).
1 Previously, in EAU, we quantified the 
nitric oxide (˙NO) production by the Griess reagent, and we 
and others evaluated the inducible nitric oxide synthase 
(iNOS) expression as the means of ˙NO production in 
inflammation.
2-6 Although quantification of nitrite, nitrate, 
nitrosylhemoglobin, and methemoglobin generally reflects 
˙NO production in the biological system, interference in these 
assays by the tissue components is well known. Nitric oxide 
synthase presumably takes L-arginine as a substrate, 
converting it to ˙NO and L-citrullin. However, in recent 
years, this direct link between NOS and ˙NO was somewhat 
weakened by several new findings: 1) Nitric oxide synthase 
does not directly synthesize ˙NO; rather, it synthesizes 
nitroxyl anion (NO
-), which can subsequently be converted 
to ˙NO in the presence of superoxide dismutase (SOD);
7 and 
2) The quantity of NOS present does not directly reflect the 
amount of ˙NO produced.
8 Therefore, a direct means of 
establishing the generation of ˙NO in EAU is necessary.Kor J Ophthalmol Vol.21, No.1, 2007
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Nitric oxide is a paramagnetic species that binds with high 
affinity to a variety of metal chelates. Therefore, electron 
spin resonance (ESR) spectroscopy with spin trapping reveals 
a direct evidence of ˙NO presence. ESR can also specifically 
detect ˙NO and distinguish it from three other redox forms. 
Two dithiocarbamate derivatives have frequently been used 
in the trapping of ˙NO in living tissues.
9-11 These are ferrous 
iron complexes of N-methyl-D-glucamine dithiocarbamate, 
(MGD)2-Fe
2+, and diethyldithiocarbamate, (DETC)2-Fe
2+. The 
high binding constant and water solubility of (MGD)2-Fe
2+ 
and the stability of the corresponding adduct [(MGD)2- 
Fe
2+-NO] have  made it possible to detect low concentrations 
of NO formed in biological systems.
12-14
Chemiluminescence is a photon emission process that is 
specifically enhanced by the presence of 5-amino-2,3-dihydro- 
1,4-phthalazinedione (luminol).
15,16 It has been widely used in 
the past in the detection of reactive radical species such as 
O2
-, hydrogen peroxide, and the hydroxyl radicals released 
from cells and tissues.
15-19
In vitro, the ˙NO and O2
- radicals are known to combine 
to form ONOO
-; the rate of the combination reaction is 
limited only by diffusion (K=3.7×10
7 M/s).
20 Peroxynitrite 
formation in vivo, however, is more difficult to detect, since 
ONOO
- is protonated with decomposition at physiological 
pH. It has recently been shown that in alkaline conditions 
(pH>9), the half-life of ONOO
- is considerably prolonged.
20 
Therefore, this type of stabilization could facilitate the 
detection of ONOO
- generated in vivo. It has been reported 
that ONOO
- can induce luminol chemiluminescence that is 
inhibited by SOD or urate. It has further been shown that the 
bicarbonate/luminol system can specifically discern the 
presence of  ONOO
- in the pool of reactive species by the 
formation of a labile intermediate ONOOC(O)O between 
ONOO
- and bicarbonate. This bicarbonate luminol adduct 
then decomposes to the active radical species, increasing the 
quantum yield to at least 2-fold from that of ONOO
- without 
bicarbonate.
21 Since no other reactive species released by the 
inflammatory phagocytes display this phenomenon, the extent 
of this increase signifies the presence of  ONOO
- in the 
active radical pool. 
In this study, we used ESR spin trapping with the 
(MGD)2-Fe
2+ complex to unequivocally detect the synthesis 
of ˙NO in the EAU retina and choroid for the first time. In 
addition to establishing the g-values and hyperfine splittings 
of the EAU samples, several controls with or without a spin 
trap were evaluated. An authentic [(MGD)2-Fe
2+-NO] 
complex was also prepared chemically to aid in the 
characterization of this adduct in the EAU retina. We have 
also quantified the photon-emitting species generated at 
the inflammatory site by luminol chemiluminescence. 
Bicarbonate was introduced in these systems, and the 
increase caused by this addition was quantified to 
demonstrate for the first time that the luminescent reactive 
species were mostly ONOO
-. 
Materials and Methods
Induction of EAU
The uveitogenic human S-antigen peptide, DTNLASS- 
TIIKEGIDRTVLG, was synthesized on 4-hydroxy- 
methylphenoxymethyl resin using an automated peptide 
synthesizer (model 430A; Applied Biosystems, Foster City, 
CA) and desalted on a Sephadex G-10 column (Sigma, St. 
Louis, MO).
1 The purity was assessed by reversed phase high 
performance liquid chromatography (Bio-Rad, Richmond, CA). 
Male Lewis rats, each weighing 150-175 g (VAF, Charles 
River Laboratory, Wilmington, MA), were given a hind 
foot-pad with 100 ㎍ of human S-antigen peptide in Freund's 
complete adjuvant to induce EAU, as previously described. 
At the time of immunization, each animal also received an 
intravenous injection of 1 ㎍ pertussis toxin (List Biological 
Laboratory, Campbell, CA) in 0.3 ml sterile saline. A total 
of 117 rats were immunized; another 12 were used as 
non-immunized controls. Immunized animals were sacrificed 
at the peak of inflammation, at between 12 and 13 days 
post-immunized. The eyes were enucleated, the anterior 
segments were removed, and the retina and choroid were 
collected. All procedures conformed to the Association for 
Research in Vision and Ophthalmology Resolution on the 
Use of Animals in Research.
Electron spin resonance spectroscopy and spin trapping 
All procedures involving a spin trap were conducted under 
dim light. The spin trap complex (MGD)2-Fe
2+ was prepared 
in 0.01 M phosphate-buffered saline (PBS) with final 
concentrations of 13.5 mM FeSO4․7H2O and 86.0 mM 
MGD (Oxis, Portland, OR). Two 10 ㎕  doses each of 
(MGD)2-Fe
2+ solution were injected into the vitreous cavity 
at different scleral sites. Similarly, two 10 ㎕  injections 
containing 0.01 M PBS only were made in the control 
animals. Ninety minutes after injection, the animals were 
sacrificed, the globes were enucleated, and the retina and 
choroids were removed. The retina and choroid from two 
eyes were combined and homogenized briefly (two seconds) 
in 0.4 ml of (MGD)2-Fe
2+ solution before the mixture was 
transferred into the ESR tube (Wilmad, Buena, NJ). The tube 
was incubated at room temperature for 30 minutes, and the 
ESR measurement commenced immediately at the end of 
incubation. For the inhibition experiments with AG, the 
globes were injected intravitreally with two 10 ㎕ doses of 
12 mM AG at different sites, two hours prior to injection of 
the spin trap (MGD)2-Fe
2+, as described above. An authentic 
(MGD)2-Fe
2+-NO complex was prepared chemically. Aliquots 
of the MGD and FeSO4․7H2O stock solution were mixed 
to yield final concentrations of 6 mM MGD and incubated 
with 10 ㎛ of the ˙NO donor, S-nitroso-N-acetyl-penicillamine 
(SNAP; Cayman Chemical Company, Ann Arbor, MI); the 
reaction product was transferred into the ESR tube.SR BAE, et al. REACTIVE NITROGEN SPECIES IN AUTOIMMUNE UVEITIS
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Fig. 1. ESR spin trapping of nitric oxide in the retina of EAU 
rats. ESR spectra were recorded from two inflamed retinas from
Lewis rats 12 days post-immunization. Ninety minutes before 
sacrifice, the eyes were injected intravitreally with the spin trap, 
(MGD)2-Fe
2+; after isolation, the retinas were incubated with 
(MGD)2-Fe
2+ for 30 minutes before ESR recording. Each 
experiment was repeated three times, using a total of six eyes 
from different animals, and a representative spectrum is shown.
normal control: non-immunized retina without spin trap; EAU 
control: EAU retina without spin trap; normal + (MGD)2-Fe
2+: 
non-immunized retina with spin trap; EAU + (MGD)2-Fe
2+: 
EAU retina with spin trap; (MGD)2-Fe
2+-NO: nitric oxide 
generated from SNAP in vitro reacted with spin trap.
Electron spin resonance spectra were recorded at 77 K 
using a Varian E-109 Spectrometer (Varian Instruments, Palo 
Alto, CA) equipped with a TE-102 cavity and a cold-finger 
dewar. Other instrument settings were as follows: 20 mW 
microwave power, 9.28 GHz frequency, 4×10
4 gain, 100 
KHz modulation frequency, 4 G modulation amplitude, 128 
ms time constant, and 2 minute scan time. Scanning was 
repeated at least four times. All ESR measurements were 
carried out using a combination of two eyes as one sample, 
and each measurement was repeated at least three or four 
times, using a total of six to eight eyes for each category of 
measurement.
Measurement of luminol chemiluminescence
A stock solution of luminol (Sigma, St. Louis, MO) was 
prepared by first dissolving 1 mg of luminol in 100 ㎕ of 
dimethyl sulfoxide and then diluting it to 10 ml with 0.01 
M PBS (pH 7.4). Exactly 400 ㎕ of the stock solution was 
diluted to 200 ml with 0.01 M PBS to provide the working 
solution. The final concentration of luminol in the working 
solution was 0.2 ㎍/ml. The final concentration of dimethyl 
sulfoxide was 0.28 mM. All procedures were conducted 
under dark illumination.
Each sample, consisting of retinas and choroids collected 
from six eyes, was placed in a polypropylene counting vial, 
and 10 ml of luminol working solution was added 
immediately before counting. Chemiluminescence was 
counted on a Packard liquid scintillation analyzer (Packard 
Instruments, Downers Grove, IL) with the operating mode set 
on single photon counting. This mode sets the two 
photomultiplier tubes in out-of-coincidence counting, thereby 
maximizing the counting efficiency for weak photon 
emission. All scintillation vials and solutions used were 
dark-adapted overnight prior to use to reduce background 
counting. Samples were counted for one minute immediately 
after mixing with luminol. The counting was then repeated 
for several cycles until the counts were stabilized. For the 
bicarbonate and inhibitor experiments, the retina/choroid 
samples were first counted until maximal stable counts were 
established, and then sodium bicarbonate (50 mM final 
concentration), SOD (5,270 units; Sigma), N-nitro-L-arginine 
methyl ester (L-NAME, 1 mM final concentration, Sigma), 
and AG (5 mM final concentration, Sigma) were added. In 
these experiments, counts without the inhibitor were first 
established by counting for 15 to 20 minutes; the inhibitor 
was then introduced, and the counting resumed for an 
additional 50 to 60 minutes. Alternatively, a parallel counting 
procedure was employed. Briefly, two vials with the same 
amount of tissue were counted for 10 to 15 minutes, 
bicarbonate/inhibitor was added to one of the vial, and 
counting for both vials was resumed for 50 to 60 minutes 
thereafter. These two counting procedures yield similar 
results. Each experiment was repeated at least three times, 
using a total of 18 globes for each category of experiment.
Results
Following an intravitreal injection of the freshly prepared 
spin trap (MGD)2-Fe
2+ into the eyes of the EAU rats, a 
prominent three-line ESR spectrum (aN=12.5 G; giso=2.04) 
was obtained (Fig. 1). The spectrum unambiguously indicated 
the adduct  [(MGD)2-Fe
2+-NO] and was consistent with 
that reported in the postischemic heart.
22,23 There was no 
appreciable signal in either the normal controls or the EAU 
rats injected with 0.01 M PBS without the spin trap (Fig. 1). 
Control animals injected with the same concentration of 
(MGD)2-Fe
2+ yielded a group of low intensity multicomponent 
signals that are not characteristic of any known radical 
species (Fig. 1). In this spectrum, one of the more obvious 
broad signals from control animals with the spin trap is 
unrelated to the [(MGD)2-Fe
2+-NO] triplet, and its identity is 
not known. This particular signal appears to be associated 
with the spin trap and some component of the naÏve retina, 
irrespective of the development of uveitis, since the 
chemically synthesized retina-free [(MGD)2-Fe
2+-NO] adduct 
resulted in no such signal. In the inhibition experiment, AG, 
which is an iNOS specific inhibitor, considerably suppressed 
the triplet signal (Fig. 2); the intensity of the [(MGD)2 
-Fe
2+-NO] signal was reduced to one-tenth or less of the 
corresponding signal without the inhibitor. In this experiment, 
AG was injected two hours before the injection of the spin 
trap. Aminoguanidine injected either three or four hours 
before administration of the spin trap resulted in further 
suppression (data not shown). The authentic [(MGD)2 Kor J Ophthalmol Vol.21, No.1, 2007
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Fig. 2. Effect of AG on the ESR spin trapping of nitric oxide
in the EAU retina. Lewis rats with EAU were injected 
intravitreally with either AG or PBS (as control) two hours 
prior to the injection of the spin trap, (MGD)2-Fe
2+. Following 
enucleation, the retina was incubated with the spin trap for 30 
minutes before ESR measurement. Each experiment was 
repeated three times using a total of six eyes. Representative
ESR spectra are shown. EAU+(MGD)2-Fe
2+: EAU retina 
with spin trap; EAU+ (MGD)2-Fe
2++ AG: EAU retina with 
spin trap plus AG.
Fig. 3. Luminol chemiluminescence of EAU and control 
retinas. The retina and choroid from Lewis rats were collected
at the peak of inflammation, 12 days post-immunization. 
Luminol (0.2 μg/ml) was added to the tissues, and the 
chemiluminescence measurement commenced immediately with a 
Packard liquid scintillation analyzer set at an out-of coincidence 
mode for single photon counting. Six sets of retina/choroid 
were used for each sample, and each measurement was repeated
three times, using a total of 18 eyes for each experimental 
category. Chemiluminescence is expressed as mean ± standard 
error for each category (n=3). An ANOVA single-parameter
comparison between maximal chemiluminescent count in EAU
vs. that in non-immunized control eyes indicated significance at
p<0.0001.
-Fe
2+-NO] prepared from the ˙NO donor, SNAP, and the spin 
trap was also used in generation of an ˙NO signal. With the 
concentration (10 μM) of SNAP used, the triplet signal 
generated was not as intense as those seen in EAU tissues; 
nevertheless, the central g-value and hyperfine splitting are 
indicative of the [(MGD)2-Fe
2+-NO] adduct and similar to 
those obtained from EAU eyes plus spin trap.
Luminol chemiluminescence was measured with the liquid 
scintillation analyzer set at out-of coincidence photon 
counting to maximize the counting efficiency. The 
chemiluminescence counting from a pool of six sets of retina 
and choroid at the peak of inflammation were on the order 
of 70,000 counts. The counts usually started immediately 
following the addition of luminol, reached a plateau in 20 
minutes, and then decayed slowly after 40 minutes. A high 
level of counting persisted even after 60 minutes. At the 
plateau, the phagocytic chemiluminescence was at least 
six-fold higher than those derived from the non-inflammatory 
source (Fig. 3). The maximum counts obtainable for a 
specific inflammatory model appear to be highly dependent 
on the degree of inflammation. In the luminol 
chemiluminescence, after stabilization of the count, the 
exogenous addition of bicarbonate increased the maximal 
counts by more than two-fold and sustained this level for two 
hours thereafter. Without bicarbonate, the counts decayed 
after one hour. The enhancement in quantum yield by the 
introduction of bicarbonate has been attributed to the 
presence of ONOO
- in the system and the subsequent 
formation of the labile intermediate ONOOC(O)O
- to 
facilitate an increase in radical generation.
21 Using 
bicarbonate/luminol chemiluminescence in the inflamed 
retina, we evaluated the combined effects of the inhibitors 
SOD (5,270 units), L-NAME (1 mM),  AG (5 mM), and AG 
(5 mM) + SOD (5,270 units).  In these experiments, the 
counts without the inhibitors were first established, the 
desired amount of inhibitor was then introduced, and 
counting was resumed for 60 minutes thereafter. The extent 
of inhibition displayed with a particular inhibitor was 
subsequently confirmed with a second procedure. Two vials, 
one with and one without inhibitor, were counted in parallel. 
In some instances, the addition of the inhibitor caused a 
temporary surge in the counts; however, these counts rapidly 
returned to their respective levels, where they remained for 
at least 40 to 50 minutes. The two procedures yielded similar 
degrees of suppression. Using these procedures, 1 mM of 
L-NAME, an inhibitor of both constitutive and inducible 
NOS, was found to give 22% suppression. With either 0.1 
or 2 mM concentrations of L-NAME, the change in the 
suppression level was found to be insignificant (data not 
shown). The inhibition was increased to 37% with 5 mM of 
AG, while SOD inhibited 40% of the chemiluminescent 
activity. In contrast with SOD, chemiluminescence was 
inhibited by 40%. A marked additive effect of 77% inhibition 
was seen with the combination of AG and SOD (Fig. 4).
Discussion
In the present study, we obtained direct evidence of ˙NO SR BAE, et al. REACTIVE NITROGEN SPECIES IN AUTOIMMUNE UVEITIS
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Fig. 4. Effects of bicarbonate, SOD, L-NAME, AG, and AG
+ SOD on luminol chemiluminescence of EAU 
retina/choroids. The enhancement by the bicarbonate (50 mM, 
n=3) addition was first determined by counting six sets of 
retina/choroid with and without bicarbonate. The countings 
from the bicarbonate/ luminol/retina system were then used as
a background level for evaluating the inhibition displayed by 
SOD (5270 units/sample; n=3), L-NAME (1 mM, n=3), AG
(5 mM, n=3), and SOD (5270 units) + AG (5 mM) (n=3). 
The counts without the inhibitor were established first, and 
then the inhibitor was added. The counting was continued until
it became stabilized (60 minutes). A set of six retinas and 
choroids were used for one measurement. Measurements were
repeated three times. All eyes used were 12 days 
post-immunization. Single-variable ANOVA was used to 
compare counts with the inhibitor groups to 
bicarbonate/luminal/chemiluminescence without inhibitors. 
*p<0.005; **p<0.005; ***p<0.0001. Control: 
non-immunized retina; EAU: EAU retina; HCO3
-: EAU retina 
+ bicarbonate; L-NAME: EAU retina + bicarbonate + 
L-NAME; AG: EAU retina + bicarbonate + AG; SOD: 
EAU retina + bicarbonate + SOD; AG + SOD: EAU retina
+ bicarbonate + SOD + AG. 
generation in the retina and choroid of EAU animals. The 
production of ˙NO was unequivocally determined by ESR, 
using (MGD)2-Fe
2+ complex as a ˙NO trap. The three-line 
spectrum (central g value of 2.04 and hyperfine splitting of 
12.5 G) obtained was characteristic of the adduct [(MGD)2 
-Fe
2+-NO]. The majority of this signal was eliminated by the 
AG intravitreally injected into the eye, as AG is a specific 
blocker for iNOS. In the inflamed retina, we also detected 
an approximately six-fold increase in chemiluminescent 
activity in comparison to those from the non-inflamed 
controls. These luminescent counts were further increased 
more than two-fold by the addition of bicarbonate to the 
isolated retina and choroid ex vivo, a phenomenon accounted 
for by the presence of a high steady-state concentration of 
ONOO
-. Further, this luminescent activity was significantly 
inhibited by the addition of either AG or SOD separately, and 
markedly inhibited by the addition of AG and SOD 
combined. Again, this suggests that both ˙NO and O2 
participate in the formation of the major chemiluminescent 
species in the inflamed retina, namely ONOO
-. Neither ˙NO 
nor O2 alone was capable of directly producing luminol 
chemiluminescence.
Nitric oxide binds to (MGD)2-Fe
2+ and forms the paramagnetic 
d
7 state mononitrosyl iron complex [(MGD)2-Fe
2+-NO], 
yielding the characteristic triplet ESR spectrum.
24 Thus, 
(MGD)2-Fe
2+ is selective in trapping ˙NO, since the trapping 
of ˙NO, one of the redox forms of nitrogen monoxide, will 
result in a diamagnetic low spin D
8 state undetectable by 
ESR spectroscopy. In the trapping of ˙NO at the peak of 
inflammation, we obtained a prominent triplet signal of the 
[(MGD)2-Fe
2+-NO] adduct 10 times higher in intensity than 
that obtained from non-immunized animals injected with the 
same spin trap. Although the symmetry of the triplet in the 
ex vivo system is often not as distinct as those from the in 
vitro system [see, for example, ref. 24], the g-values and 
hyperfine splittings obtained are comparable to those reported 
in tissues for the same radical.
25,26 We have also obtained a 
signal from an authentic adduct, prepared independently from 
(MGD)2-Fe
2+ and the ˙NO donor SNAP; the spectrum and the 
g-value were very much in agreement with those from the 
EAU retinas. Little or no NO production is derived from 
injected (MGD)2-Fe
2+, as shown in control rats injected with 
(MGD)2-Fe
2+. This signal was also absent in EAU rats 
without the spin trap, indicating efficient trapping by 
(MGD)2-Fe
2+ and subsequent stabilization and accumulation 
of (MGD)2-Fe
2+-NO in the retina.
In this experiment, intravitreally injected AG caused nearly 
complete suppression of the [(MGD)2-Fe
2+-NO] signal in the 
retina. Aminoguanidine, a nucleophilic hydrazine compound, 
is a known selective inhibitor of iNOS. The inhibitory action 
is believed to act on the enzymatic activity of iNOS.
27 
Therefore, the marked suppressive effect of AG injected 3.5 
hours prior to the sacrifice of the animal implies: first, that 
a large proportion of ˙NO synthesis is L-arginine/ 
iNOS-mediated, and second, that there is a relatively fast 
turnover of ˙NO in the retina, so that the depletion of 
endogenous iNOS for at least 3.5 hours causes a significant 
reduction in the retinal ˙NO concentration, as indicated by 
ESR spin trapping. In the presence of O2 at the site of ˙NO 
generation, the major route of ˙NO disappearance is by a fast 
combination reaction to yield ONOO
-. In the absence of O2, 
˙NO is oxidized and disproportionated to yield nitrite and 
nitrate, which accumulate as stable products in tissues. With 
the concentrations injected into the eye for the present study, 
the (MGD)2-Fe
2+ complex appears to compete favorably with 
other fates of ˙NO in the retina, since the adduct [(MGD)2 
-Fe
2+-NO] obtained was in relatively high concentrations.
The (MGD)2-Fe
2+ complex was delivered to the retina both 
by intravitreal injections to the eyes of live animals and by 
subsequent incubation of the isolated retinas with the 
(MGD)2-Fe
2+ complex. Spin trapping of endogenously 
generated radicals within the retina has never been attempted 
in the past. The concentrations of (MGD)2-Fe
2+ used in the 
present study were comparable to those reported for other 
tissues.
9,11,14 These (MGD)2-Fe
2+ concentrations have been 
shown to pose no deleterious effects.
9,11,28 During the course 
of spin trapping, the free iron was unlikely to be present in Kor J Ophthalmol Vol.21, No.1, 2007
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the retina, since there is an excess amount of MGD present 
for chelating exogenous iron (MGD:iron ratio=5:1). 
Therefore, it is safe to conclude that intravitreal injections of 
(MGD)2-Fe
2+ complex will not lead to any deleterious 
reactions, including the stimulation of ˙NO production. This 
assumption was subsequently verified by the experiment in 
which control animals injected with the same concentration 
of (MGD)2-Fe
2+ gave no significant [(MGD)2-Fe
2+-NO] signal 
(Fig. 1).
Chemiluminescence counts for the phagocytic activity in 
inflammation appear to be highly system-dependent, possibly 
because of differences in the extent of inflammation and the 
size of tissues used. The reported maximal counts have been 
highly variable.
19 In this study, the chemiluminescence counts 
usually displayed a plateau at 20 to 40 minutes after the 
addition of luminol and decreased thereafter. The addition of 
bicarbonate to the inflamed retina rapidly increased the 
counts to more than two-fold. The half-life of ONOO
- was 
prolonged in the alkaline solution, since the protonation/ 
decomposition reaction was largely eliminated. Therefore, the 
addition of bicarbonate stabilizes ONOO
-, thus facilitating the 
detection of ONOO
- in tissues. Moreover, ONOO
- appears to 
be the major species in the pool of reactive radical species, 
since the two-fold enhancement obtained by adding the 
bicarbonate is similar to the in vitro observations reported 
with the pure ONOO
- preparation.
21
The exact pathway by which bicarbonate enhances the 
ONOO
- luminescence is not known. The light-emitting 
excited species is apparently produced by ONOO
- and HCO3
- 
interactions. Although several thermodynamically feasible 
speculations have been advanced, the exact nature of this 
excited species is yet to be proved.
29 One fate for this 
unstable intermediate is to proceed to a facile decomposition 
that yields O2
-.
21 Since the inhibitory effect of SOD (Fig. 4) 
indicates the participation of O2
- in chemiexcitation, the 
increased production of O2
- could, therefore, translate to a 
higher photon quantum yield.
The results of the bicarbonate luminol chemiluminescence 
indicate that although ONOO
- is short-lived at physiological 
pH (t1/2<1 s), the inflammatory infiltrates are viable for a 
period of hours after the sacrifice of animals. During this 
period, these inflammatory cells were continuously activated 
to express NOS and NADPH oxidase and to produce NO and 
O2
-. Superoxide is known to participate not by directly 
reacting to luminol, but rather by reacting with the luminol 
radical formed by the one-electron oxidation of luminol by 
oxidants, such as the OH˙ radical, lipid hydroperoxide, or 
other species with similar reactivity.
17 Therefore, the 
observed inhibitory effect of SOD can arise from the 
inhibition of ONOO
- formation from O2
- and ˙NO, or from 
the reaction of O2
- with luminol radicals. In this context, the 
less than 50% inhibition exhibited by SOD might reflect the 
accessibility of SOD to the O2
--generating site in the retina 
within the short time frame between SOD addition and 
measurement of the photon emission.
The exogenous addition of L-NAME or AG inhibits the 
function of NOS. Since AG is a specific inhibitor of iNOS 
and L-NAME is an inhibitor of both inducible and 
constitutive NOS, the larger suppression seen by AG might 
imply that iNOS is the predominant form in the production 
of ˙NO in this system. However, even the suppression seen 
with AG is less than 50%. In this experiment, AG was added 
immediately before the addition of luminol and the 
measurement of chemiluminescence. Therefore, only the 
amount of ˙NO newly synthesized within this time frame will 
be affected. The suppression, however, was more remarkable 
when instantaneous scavenging of O2
- by SOD was added to 
this iNOS blocker.
Bicarbonate anion is an abundant constituent of the 
extracellular milieu, present at concentrations as high as 25 
mM. Therefore, in biological systems, bicarbonate anion 
interacts rapidly with ONOO
- to form ONOOC(O)O
- and 
enhances the toxicity of ONOO
-, as seen in bicarbonate 
luminol chemiluminescence. Based on kinetic considerations, 
the HCO3
-/CO pair should compete favorably with other 
biological targets, such as sulfhydryls, for reaction with 
ONOO
- in the extracellular space.
29 Heterolytic cleavage of 
ONOOC(O)O
- will also give rise to a potent nitrating agent 
that will regenerate HCO3
-. This reaction is consistent with 
the catalytic effect of bicarbonate on ONOO
--dependent 
nitration of aromatics, including tyrosine, reported 
previously.
30,31
In summary, we have demonstrated the production of ˙NO 
in EAU by ESR spin trapping. This method surpasses any 
other method for indirectly detecting the presence of ˙NO 
species in the tissue. This reactive nitrogen species then 
forms the potent biological oxidant ONOO
- in the inflamed 
retina and choroid. Recognition of the species responsible for 
the tissue injury in EAU will aid in developing therapeutic 
interventions for the prevalent intraocular inflammations.
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